The plans from the Department of Health and Human Services come on the heels of criticism Ozempic and other weight loss medications received by RFK Jr.

The good news is that HHS recognizes that vitally important anti-obesity medicines like Wegovy and Zepbound should be made available to all Americans, regardless of income. The bad news is that unless ...

Medicare and Medicaid would cover weight-loss drugs like Wegovy and Ozempic under a new rule proposed by President Joe Biden ...

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were mostly higher early Tuesday after the Biden administration proposed a rule that would allow Medicare ...

Medicare has been barred from offering the drugs under a decades-old law that prohibits the government-backed insurance ...

Novo Nordisk faces challenges in weight-loss sector, but acquisition and strong diabetes portfolio position it for future ...

U.S. stocks climbed Monday as investors cheered President-elect Donald Trump’s choice for Treasury secretary ahead of a ...

The former U.S. Attorney General headlined the Government Investigations & Civil Litigation Institute conference in Fort Lauderdale, Florida.

Attention then turns to US data as an abbreviated trading week across the Atlantic progresses. The personal consumption expenditures inflation gauge is released on Wednesday, as it the latest initial ...

Robert F. Kennedy Jr.'s potential appointment to HHS has spooked Eli Lilly stock and stocks tied to popular weight-loss drugs.

Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish ...

As far as competition goes, Eli Lilly is one of the two current leaders in the weight loss space, along with Novo Nordisk.